https://doi.org/10.4081/itjm.2026.2656
Proton pump inhibitor prescribing at hospital discharge: a real-world analysis from two Italian internal medicine units
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 23 September 2026
To the Editor,
Proton pump inhibitors are highly effective for acid-related disorders and for gastrointestinal protection in selected high-risk patients...
Downloads
Scarpignato C, Gatta L, Zullo A, et al. Effective and safe proton pump inhibitor therapy in acid-related diseases: a position paper addressing benefits and potential harms of acid suppression. BMC Med 2016;14:179. DOI: https://doi.org/10.1186/s12916-016-0718-z
National Institute for Health and Care Excellence. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. NICE guideline CG184. London, UK: NICE; 2022.
Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ 2008;336:2-3. DOI: https://doi.org/10.1136/bmj.39406.449456.BE
Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician 2017;63:354-64.
Visconti M. Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage? Ital J Med 2015;9:217-28. DOI: https://doi.org/10.4081/itjm.2015.562
Bell CM, Brener SS, Gunraj N, et al. Association of ICU or hospital discharge with unintentional continuation of medications intended for acute illness. JAMA 2011;306:2525-33. DOI: https://doi.org/10.1001/jama.2011.1206
Targownik LE, Fisher DA, Saini SD. AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review. Gastroenterology 2022;162:1334-42. DOI: https://doi.org/10.1053/j.gastro.2021.12.247
Wilsdon TD, Hendrix I, Thynne TR, Mangoni AA. Effectiveness of interventions to reduce chronic proton pump inhibitor use: a systematic review. Br J Clin Pharmacol 2017;83:662-75.
Agenzia Italiana del Farmaco. Nota AIFA N01: indicazioni per la prescrivibilità a carico del SSN degli inibitori di pompa protonica. Determina PRES n. 238/2026. Rome, Italy: AIFA; 2026.
Osservatorio Nazionale sull'Impiego dei Medicinali. L'uso dei farmaci in Italia. Rapporto nazionale anno 2024. Rome, Italy: Agenzia Italiana del Farmaco; 2025.
Almegren MO. Assessment and predictors of inappropriate dose of direct oral anticoagulants. Ital J Med 2024;18:1679. DOI: https://doi.org/10.4081/itjm.2024.1679
Maiello M, Proce F, Caputo C, et al. Continuity of care in acute coronary syndrome: why dedicated clinics for post-acute coronary syndrome management make the difference. Ital J Med 2025;19:2054. DOI: https://doi.org/10.4081/itjm.2025.2054
CRediT authorship contribution
Paola Gnerre: concept and design of the study and draft of the manuscript. All authors: data collection, data interpretation, and critical revision of the manuscript. All authors read and approved the final version and agreed to be accountable for all aspects of the work.
How to Cite
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.